The Cellular Therapy Products Market is gaining strong momentum as regenerative medicine technologies mature, CAR-T and other immune cell therapies expand, and stem cell-based treatments advance across oncology, autoimmune, and degenerative diseases. Depending on scope, recent estimates value the market between USD 5.6 and 15.3 billion in 2024–2025, with projections rising to USD...
